FDA Inspection 1323324 — The Mount Sinai Hospital

The Mount Sinai Hospital — FEI 2470025

The FDA completed an inspection of The Mount Sinai Hospital on Jun 8, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 8, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.